Cite
Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
MLA
O’Neill, Joseph, et al. “Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.” Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, vol. 42, no. 12, Nov. 2017, pp. 2414–22. EBSCOhost, https://doi.org/10.1038/npp.2017.77.
APA
O’Neill, J., Piacentini, J., Chang, S., Ly, R., Lai, T. M., Armstrong, C. C., Bergman, L., Rozenman, M., Peris, T., Vreeland, A., Mudgway, R., Levitt, J. G., Salamon, N., Posse, S., Hellemann, G. S., Alger, J. R., McCracken, J. T., & Nurmi, E. L. (2017). Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 42(12), 2414–2422. https://doi.org/10.1038/npp.2017.77
Chicago
O’Neill, Joseph, John Piacentini, Susanna Chang, Ronald Ly, Tsz M Lai, Casey C Armstrong, Lindsey Bergman, et al. 2017. “Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.” Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 42 (12): 2414–22. doi:10.1038/npp.2017.77.